Browse by category

IFSO European Chapter (IFSO-EC) has come a long way from the humble beginnings at the Prague IFSO European Symposium in 2004. The main...

Allurion Technologies is relaunching the Allurion Balloon in France after the Agence nationale de sécurité du médicament et des produits...

Semaglutide could also help people cut down on their alcohol intake, according to the findings from the ‘Human Laboratory Screening of...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Bariatric and metabolic surgery (BMS) is safe and induces substantial weight loss that reduces the need for T2DM medications, according...

The Diabetes Remission Index (DRI) and Weight Loss-Adjusted Diabetes Remission Index (W-DRI) models – used to assess type 2 diabetes...

Adolescents who perceive themselves as overweight are three times more likely to consider committing self-harm compared to those who do...

Response Pharmaceuticals has completed enrolment in a Phase 2 trial evaluating the company’s drug candidate, RDX-002, for post-GLP-1...

Palatin Technologies has completed its Phase 2 BMT-801 clinical study of the co-administration of MC4R bremelanotide + GLP-1/GIP...

Wave Life Sciences has announced clinical trial application (CTA) approval and initiation of the Phase 1 INLIGHT clinical trial of...